Log In
Print
BCIQ
Print
Print this Print this
 

emricasan (IDN-6556, PF-03491390, PF-3491390)

  Manage Alerts
Collapse Summary General Information
Company Conatus Pharmaceuticals Inc.
DescriptionPan-caspase inhibitor
Molecular Target Caspases
Mechanism of ActionCaspase inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today